EUVIMEDEUVIMED entdecken
Open Access

Genetically engineered transfusable platelets using mRNA lipid nanoparticles

Jerry Leung iD, Colton Strong iD, Katherine E Badior iD, Madelaine Robertson iD, Xiaowu Wu iD, Michael A Meledeo iD, Emma Kang, Manoj Paul, Yusuke Sato iD, Hideyoshi Harashima, Andrew P Cap iD, Dana V Devine und 3 weitere

Science Advances · 2023-12 · 9 (48)

DOI: 10.1126/sciadv.adi0508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023-12. Verfasst von Jerry Leung und 14 weiteren Autor:innen. Beteiligte Einrichtung: Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada. Hauptthemen laut MEDLINE: Blood Platelets, Hemostatics. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Defense Investigator-Initiated Research Award, Frederick Banting and Charles Best Doctoral Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelet transfusions are essential for managing bleeding and hemostatic dysfunction and could be expanded as a cell therapy due to the multifunctional role of platelets in various diseases. Creating these cell therapies will require modifying transfusable donor platelets to express therapeutic proteins. However, there are currently no appropriate methods for genetically modifying platelets collected from blood donors. Here, we describe an approach using platelet-optimized lipid nanoparticles containing mRNA (mRNA-LNP) to enable exogenous protein expression in human and rat platelets. Within the library of mRNA-LNP tested, exogenous protein expression did not require nor correlate with platelet activation. Transfected platelets retained hemostatic function and accumulated in regions of vascular damage after transfusion into rats with hemorrhagic shock. We expect this technology will expand the therapeutic potential of platelets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsHemostaticsHumansRatsAnimalsRNA, MessengerBlood DonorsLiposomesNanoparticles

Substanzen

RNA, MessengerHemostaticsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada.
  • Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, V6T 1Z3, Canada.
  • Centre for Blood Research, University of British Columbia, Vancouver, V6T 1Z3, Canada.
  • NanoMedicines Research Group, University of British Columbia, Vancouver, V6T 1Z3, Canada.
  • Blood Research Institute, Versiti, Milwaukee,WI 53226, USA.
  • Blood and Shock Resuscitation Program, United States Army Institute of Surgical Research, JBSA-FT Sam Houston, San Antonio, TX 78234, USA.

ORCID-Profile: Jerry Leung, Colton Strong, Katherine E Badior, Madelaine Robertson, Xiaowu Wu, Michael A Meledeo, Yusuke Sato, Andrew P Cap, Eric Jan, Christian J Kastrup

Förderung

  • U.S. Department of Defense Investigator-Initiated Research Award
  • Frederick Banting and Charles Best Doctoral Award

Zitieren

APA

Leung, J., Strong, C., Badior, K. E., Robertson, M., Wu, X., Meledeo, M. A., Kang, E., Paul, M., Sato, Y., Harashima, H., Cap, A. P., Devine, D. V., Jan, E., Cullis, P. R., & Kastrup, C. J. (2023). Genetically engineered transfusable platelets using mRNA lipid nanoparticles. Science Advances, 9(48). https://doi.org/10.1126/sciadv.adi0508

Vancouver

Leung J, Strong C, Badior KE, Robertson M, Wu X, Meledeo MA, et al. Genetically engineered transfusable platelets using mRNA lipid nanoparticles. Science Advances. 2023;9(48). doi:10.1126/sciadv.adi0508

BibTeX
@article{Leung2023,
  author = {Leung, Jerry and Strong, Colton and Badior, Katherine E and Robertson, Madelaine and Wu, Xiaowu and Meledeo, Michael A and Kang, Emma and Paul, Manoj and Sato, Yusuke and Harashima, Hideyoshi and Cap, Andrew P and Devine, Dana V and Jan, Eric and Cullis, Pieter R and Kastrup, Christian J},
  title = {Genetically engineered transfusable platelets using mRNA lipid nanoparticles},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {48},
  doi = {10.1126/sciadv.adi0508}
}
Kostenlos starten →